secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2025-11-26T23:59:59+00:00
Accession:  0001601830-25-000172
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Recursion issues 7.1M shares to Tempus AI for license fees; registers for resale
--------------------------------------------------------------------------------

- Issued 7,088,742 Class A shares to Tempus AI on Nov 24, 2025 as payment for annual license fees.
- Shares registered for resale via prospectus supplement filed Nov 26, 2025 under existing shelf registration.
- Issuance stems from Master Agreement dated Nov 9, 2023, as previously disclosed in an 8-K.
- Resale registration may allow Tempus to sell shares, creating potential dilution for existing holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000172/0001601830-25-000172-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000172/rxrx-20251126.htm
  HTML page:      https://secwatch.observer/filing/0001601830-25-000172

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer